|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | MolDock: a new technique for high- accuracy molecular docking显示文摘 | Thomsen R Christensen MH | 2006 | J Med Chem2006，49，11： | 1 |
| 2 | Dula- glutide,a long-acting GLP-I analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes 显示文摘 | Jimenez-Solem E Rasmussen MH Christensen M | 2010 | Curr Opin Mol Ther2010，12，6： | 1 |
| 3 | 怎样护理糖尿病病人的双脚显示文摘在美国,非创伤性截肢中半数以上系糖尿病的并发症所致。从入院病人看,每5个糖尿病患者就有1名是来治脚部溃疡的。如何判断脚的情况首先询问患者怎样照料自己的脚,从中了解患者照料自己的能力和自我照料中的缺点。 | Christensen MH 张海娟 董莉 | 1991 | 国外医学(护理学分册)1991，10，5： | 1 |
| 4 | Caffe- ine,but not bicarbonate,improves 6 min maximal per- formance in elite rowers显示文摘 | Christensen PM Petersen MH Friis SN | 2014 | Appl Physiol Nutr Metab2014，39，9： | 1 |
| 5 | Prevalence of polycystic ovary syndrome in adolescents 显示文摘 | Christensen SB Black MH Smith N | 2013 | Fertil Steril2013，100，2： | 1 |
| 6 | Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes显示文摘 | JIMENEZ-SOLEM E RASMUSSEN MH CHRISTENSEN M | 2010 | Curr Opin Mol Ther2010，12，6： | 1 |
| 7 | N-terminal probrain natriuretie peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome显示文摘 | Olsen MH Hansen TW Christensen MK | 2005 | Hypertension2005，46，4： | 1 |
| 8 | N-terminal pro- brain natriuretic peptide predicts is inversely related to metabolic cardiovascular risk factors and the metabolic syndyome显示文摘 | Olsen MH Hansen TW Christensen MK | 2005 | Hyoertension2005，46，： | 1 |
| 9 | Moldock a new technique tor high- accuracy molecular docking 显示文摘 | Thomsen R Christensen MH | 2006 | J Med Chem2006，49，11： | 1 |
| 10 | Prevalence of polycystie ovary syndrome in adolescents 显示文摘 | Christensen SB Black MH Smith N | 2013 | Fertil Steril2013，100，2： | 1 |
| 11 | 1,25-dihydroxyvi- tamin D and the vitamin D receptor gene polymorphism Apal influ- ence bone mineral density in primary hyperparathyrnidism 显示文摘 | Christensen MH Apalset EM Nordb Y | 2013 | PLoS One2013，8，56： | 1 |
| 12 | Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes显示文摘 | Jimenez-Solem E Rasmussen MH Christensen M | 2010 | Curt Opin Mol Ther2010，12，6： | 1 |
| 13 | Dulaglutide,a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes显示文摘 | Jimenez-Solem E Rasmussen MH Christensen M | 2010 | Curr Opin Mol Ther2010，12，6： | 1 |
| 14 | Radionuclide treatment of painful bone metastases in patients with breast cancer: a systematic review 显示文摘 | Christensen MH Petersen LJ | 2012 | Cancer Treat Rev2012，38，2： | 1 |
| 15 | Plasminogcn activator in- hibitor-I impairs alveolar epithelial repair:by binding to vitronectin 显示文摘 | Lazar MH Christensen PJ Du M | 2004 | Am J Respir Cell Mol Biol2004，31，6： | 1 |
| 16 | Radionuclide treatment of painful bonemetastases in patients with breast cancer:a systematic review显示文摘 | Christensen MH Petersen LJ | 2012 | Cancer Treat Revi2012，38，2： | 1 |
| 17 | Plasminogen activator inhibitor 1 impairs alveolar epithelial repair by binding to vitronectin 显示文摘 | Lazar MH Christensen PJ Du M te al | 2004 | Am J Respir Cell Mol Biol2004，31，6： | 1 |
| 18 | Prevalence of polycystic ovary syndrome in adolescents 显示文摘 | Christensen SB Black MH Smith N | 2013 | Fertil Steril2013，100，2： | 1 |
| 19 | Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin 显示文摘 | Lazar MH Christensen PJ Du M | 2004 | Am J Respir Cell Mol Biol2004，31，6： | 1 |
| 20 | Dulaglutide, a long-acting GLP-1 analog fused with an Fc an- tibody fragment for the potential treatment of type 2 diabetes显示文摘 | JIMENEZ-SOLEM E RASMUSSEN MH CHRISTENSEN M | 2010 | Curr Opin Mo! Ther2010，12，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员